scholarly journals Efficacy of pulmonary rehabilitation on patients with non-cystic bronchiectasis according to disease severity

2021 ◽  
Vol 69 (4) ◽  
pp. 449-457
Author(s):  
Sami Deniz ◽  
Hülya Şahin ◽  
Ahmet Emin Erbaycu
2008 ◽  
Vol 102 (1) ◽  
pp. 162-171 ◽  
Author(s):  
Rosalie J. Huijsmans ◽  
Arnold de Haan ◽  
Nick N.H.T. ten Hacken ◽  
Renata V.M. Straver ◽  
Alex J. van’t Hul

2013 ◽  
Vol 8 ◽  
Author(s):  
Athanasios Tselebis ◽  
Dionisios Bratis ◽  
Argiro Pachi ◽  
Georgios Moussas ◽  
Ioannis Ilias ◽  
...  

Background: The presence of anxiety and depressive symptoms in COPD patients has been acknowledged for many years. The preponderance of recent studies supports the utility of pulmonary rehabilitation programs to reduce the levels of depression and anxiety in these patients. The aim of this study is to investigate possible changes in levels of anxiety and depression among patients enrolled in a pulmonary rehabilitation program, along with the role of disease severity in these changes. Methods: In 101 COPD patients, who attended a pulmonary rehabilitation program, levels of trait anxiety (STAI) and depressive symptoms (BDI) were assessed at the beginning and at the end of the program. Age, sex, level of education in years and stage of disease severity were recorded. Results: Our study included 80 male and 21 female patients. Mean age and mean education level were 64.1 ± 8.1 and 11.3 ± 4.1 years, respectively. Regarding COPD staging, 11 patients suffered from mild, 16 from moderate, 47 from severe and 27 from very severe COPD. Significant decreases in anxiety (from 39.7 to 34.0, p < 0.001) and depression rates (from 10.7 to 6.3, p < 0.001) were observed. A statistically significant reduction in anxiety and depression was revealed (p < 0.05)at all stages of COPD. Conclusion: Pulmonary rehabilitation programs should be offered to all COPD patients irrespective of disease severity, since they all lead to improvement in anxiety and depressive symptoms.


1999 ◽  
Vol 56 (3) ◽  
pp. 131-135
Author(s):  
Villiger

Die Pulmonale Rehabilitation (PR) ist ein wichtiger Bestandteil der Behandlung der chronisch obstruktiven Lungenkrankheiten (COPD und Emphysem). Es ist heute wissenschaftlich erwiesen und durch Metaanalysen bestätigt, daß diese Programme die Leistungsfähigkeit und die Lebensqualität verbessern sowie die Symptome reduzieren. Weiterhin bestehen Hinweise, daß durch die PR der Medikamentenverbrauch reduziert und das Überleben verbessert werden kann. Die PR ist multidisziplinär. Von zentraler Bedeutung sind neben der Medizinischen Trainingstherapie (Ausdauer/Kraft) Physiotherapie, Patientenschulung, psychosoziale Betreuung und Ernährungsberatung. Die PR scheint besonders geeignet für Patienten mit geringer Leistungsfähigkeit, Muskelschwäche, ausgeprägten subjektiven Symptomen und schlechter Lebensqualität. Der Ort der Rehabilitation richtet sich nach dem Schweregrad der Symptome, den Anforderungen an das Reha-Team und den lokalen Möglichkeiten.


Author(s):  
Jeniffer Danielle M. Dutra ◽  
Quelson Coelho Lisboa ◽  
Silvia Marinho Ferolla ◽  
Carolina Martinelli M. L. Carvalho ◽  
Camila Costa M. Mendes ◽  
...  

Abstract. Some epidemiological evidence suggests an inverse correlation between non-alcoholic fatty liver disease (NAFLD) frequency and vitamin D levels. Likewise, a beneficial effect of vitamin D on diabetes mellitus (DM) and insulin resistance has been observed, but this is an unsolved issue. Thus, we aimed to investigate the prevalence of hypovitaminosis D in a NAFLD Brazilian population and its association with disease severity and presence of comorbidities. In a cross-sectional study, the clinical, biochemical and histological parameters of 139 NAFLD patients were evaluated according to two different cut-off points of serum 25-hydroxyvitamin D levels (20 ng/mL and 30 ng/mL). The mean age of the population was 56 ± 16 years, most patients were female (83%), 72% had hypertension, 88% dyslipidemia, 46% DM, 98% central obesity, and 82% metabolic syndrome. Serum vitamin D levels were < 30 ng/mL in 78% of the patients, and < 20 ng/mL in 35%. The mean vitamin D level was 24.3 ± 6.8 ng/mL. The comparison between the clinical, biochemical and histological characteristics of the patients according to the levels of vitamin D showed no significant difference. Most patients with NAFLD had hypovitaminosis D, but low vitamin D levels were not related to disease severity and the presence of comorbidities.


Sign in / Sign up

Export Citation Format

Share Document